Impact of effective refractory period personalization on arrhythmia vulnerability in patient-specific atrial computer models.
- Published in:
- EP: Europace, 2024, v. 26, n. 10, p. 1, doi. 10.1093/europace/euae215
- By:
- Publication type:
- Article
Works by Dasí, Albert
Results: 4
1
2
In Silico TRials guide optimal stratification of ATrIal FIbrillation patients to Catheter Ablation and pharmacological medicaTION: the i-STRATIFICATION study.
- Published in:
- EP: Europace, 2024, v. 26, n. 6, p. 1, doi. 10.1093/europace/euae150
- By:
- Publication type:
- Article
3
What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria.
- Published in:
- Journal of Physiology, 2023, v. 601, n. 18, p. 4013, doi. 10.1113/JP284730
- By:
- Publication type:
- Article
4
In-silico drug trials for precision medicine in atrial fibrillation: From ionic mechanisms to electrocardiogram-based predictions in structurally-healthy human atria.
- Published in:
- Frontiers in Physiology, 2022, v. 13, p. 1, doi. 10.3389/fphys.2022.966046
- By:
- Publication type:
- Article